Q&A column, 4/17 - CAP TODAY
Multi-institutional Assessment of Pathologist Scoring HER2 Immunohistochemistry - Modern Pathology
Frontiers | HER2 Low, Ultra-low, and Novel Complementary Biomarkers: Expanding the Spectrum of HER2 Positivity in Breast Cancer
![PDF] American Society of Clinical Oncology/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/32ece30ca42786761f6116717941ca1d4449b4bc/8-Figure1-1.png "PDF] American Society of Clinical Oncology/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer. | Semantic Scholar")
PDF] American Society of Clinical Oncology/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer. | Semantic Scholar
Figure 3 from Recommendations for human epidermal growth factor receptor 2 testing in breast cancer: American Society of Clinical Oncology/College of American Pathologists clinical practice guideline update. | Semantic Scholar
![PDF] Assessment of ERBB2/HER2 Status in HER2-Equivocal Breast Cancers by FISH and 2013/2014 ASCO-CAP Guidelines | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/d99c6aa1dcc660fbabc1af5e20d607b8747a33a1/3-Figure1-1.png "PDF] Assessment of ERBB2/HER2 Status in HER2-Equivocal Breast Cancers by FISH and 2013/2014 ASCO-CAP Guidelines | Semantic Scholar")
PDF] Assessment of ERBB2/HER2 Status in HER2-Equivocal Breast Cancers by FISH and 2013/2014 ASCO-CAP Guidelines | Semantic Scholar
HER2 TESTING IN BREAST CANCER Clinical Practice Guideline Update
Digital validation of breast biomarkers (ER, PR, AR, and HER2) in cytology specimens using three different scanners | Modern Pathology
CAP Quantitative Image Analysis of HER2 Immunohistochemistry for Breast Cancer
CAP and ASCO Press Release - College of American Pathologists
Development and validation of the new HER2DX assay for predicting pathological response and survival outcome in early-stage HER2-positive breast cancer - eBioMedicine
HER2 Testing and Clinical Decision Making in Gastroesophageal Adenocarcinoma
![PDF] THE BOTTOM LINE Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer : American Society of Clinical Oncology / College of American Pathologists Clinical Practice Guideline Focused Update Guideline Questions | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/747f72db6685fa520b07391fb016bac6754d7633/6-Table1-1.png "PDF] THE BOTTOM LINE Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer : American Society of Clinical Oncology / College of American Pathologists Clinical Practice Guideline Focused Update Guideline Questions | Semantic Scholar")
PDF] THE BOTTOM LINE Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer : American Society of Clinical Oncology / College of American Pathologists Clinical Practice Guideline Focused Update Guideline Questions | Semantic Scholar
PDF) Impact of the 2018 ASCO/CAP guidelines on HER2 fluorescence in situ hybridization interpretation in invasive breast cancers with immunohistochemically equivocal results
Pathologist's Corner – Dr. Hon on Breast Cancer Tissue Handling and Updates for Her-2 Testing
Frontiers | HER2 Low, Ultra-low, and Novel Complementary Biomarkers: Expanding the Spectrum of HER2 Positivity in Breast Cancer
![PDF] Recommendations for human epidermal growth factor receptor 2 testing in breast cancer: American Society of Clinical Oncology/College of American Pathologists clinical practice guideline update. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/22a3980f48cd672241df3eaefc79b28510b3576b/10-Figure2-1.png "PDF] Recommendations for human epidermal growth factor receptor 2 testing in breast cancer: American Society of Clinical Oncology/College of American Pathologists clinical practice guideline update. | Semantic Scholar")
PDF] Recommendations for human epidermal growth factor receptor 2 testing in breast cancer: American Society of Clinical Oncology/College of American Pathologists clinical practice guideline update. | Semantic Scholar
![PDF] THE BOTTOM LINE Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer : American Society of Clinical Oncology / College of American Pathologists Clinical Practice Guideline Focused Update Guideline Questions | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/747f72db6685fa520b07391fb016bac6754d7633/8-Table2-1.png "PDF] THE BOTTOM LINE Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer : American Society of Clinical Oncology / College of American Pathologists Clinical Practice Guideline Focused Update Guideline Questions | Semantic Scholar")
PDF] THE BOTTOM LINE Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer : American Society of Clinical Oncology / College of American Pathologists Clinical Practice Guideline Focused Update Guideline Questions | Semantic Scholar
![PDF] HER2 Gene Amplification Testing by Fluorescent In Situ Hybridization (FISH): Comparison of the ASCO-College of American Pathologists Guidelines With FISH Scores Used for Enrollment in Breast Cancer International Research Group Clinical](https://d3i71xaburhd42.cloudfront.net/c7289407931d6ff274350f21b4024900edadc66e/2-Figure1-1.png "PDF] HER2 Gene Amplification Testing by Fluorescent In Situ Hybridization (FISH): Comparison of the ASCO-College of American Pathologists Guidelines With FISH Scores Used for Enrollment in Breast Cancer International Research Group Clinical")
PDF] HER2 Gene Amplification Testing by Fluorescent In Situ Hybridization (FISH): Comparison of the ASCO-College of American Pathologists Guidelines With FISH Scores Used for Enrollment in Breast Cancer International Research Group Clinical
![PDF] Recommendations for human epidermal growth factor receptor 2 testing in breast cancer: American Society of Clinical Oncology/College of American Pathologists clinical practice guideline update. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/5b573aa3e76dd22869e0e5d0714a1a897b9647ef/22-Table1-1.png "PDF] Recommendations for human epidermal growth factor receptor 2 testing in breast cancer: American Society of Clinical Oncology/College of American Pathologists clinical practice guideline update. | Semantic Scholar")
PDF] Recommendations for human epidermal growth factor receptor 2 testing in breast cancer: American Society of Clinical Oncology/College of American Pathologists clinical practice guideline update. | Semantic Scholar
Frontiers | Breast Cancer With a HER2 IHC2+ and FISH HER2/CEP17 Ratio ≥2.0 and an Average HER2 Gene Copy Number <4.0 per Tumor Cell: HER2 mRNA Overexpression Is a Rare Event
![PDF] Recommendations for human epidermal growth factor receptor 2 testing in breast cancer: American Society of Clinical Oncology/College of American Pathologists clinical practice guideline update. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/22a3980f48cd672241df3eaefc79b28510b3576b/4-Figure1-1.png "PDF] Recommendations for human epidermal growth factor receptor 2 testing in breast cancer: American Society of Clinical Oncology/College of American Pathologists clinical practice guideline update. | Semantic Scholar")
PDF] Recommendations for human epidermal growth factor receptor 2 testing in breast cancer: American Society of Clinical Oncology/College of American Pathologists clinical practice guideline update. | Semantic Scholar
Rate of reclassification of HER2-equivocal breast cancer cases to HER2-negative per the 2018 ASCO/CAP guidelines and response of HER2-equivocal cases to anti-HER2 therapy | PLOS ONE
